Showing results (1371-1380 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|May 10, 2007
Economic evaluation of treatment administration strategies of ganciclovir for cytomegalovirus retinitis in HIV/AIDS patients in Thailand: a simulation studyKanlaya Teerawattananon, Saniorn Iewsakul, Chawewan Yenjitr, et al.
Pharmacoeconomics|July 31, 2009
Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age groupAnthony T Newall, Heath Kelly, Stuart Harsley, et al.
Pharmacoeconomics|July 31, 2009
How to deal with cost differences at baselineAntoinette D I van Asselt, Ghislaine A P G van Mastrigt, Carmen D Dirksen, et al.
Pharmacoeconomics|September 18, 2009
A cost-effectiveness analysis to illustrate the impact of cost definitions on results, interpretations and comparability of pharmacoeconomic studies in the USSandra L Tunis
Pharmacoeconomics|September 18, 2009
Comparing three software tools for implementing markov models for health economic evaluationsPetra Menn, Rolf Holle
Pharmacoeconomics|August 12, 2009
Calibration methods used in cancer simulation models and suggested reporting guidelinesNatasha K Stout, Amy B Knudsen, Chung Yin Kong, et al.
Pharmacoeconomics|August 12, 2009
Cost utility of adalimumab versus infliximab maintenance therapies in the United States for moderately to severely active Crohn's diseaseAndrew P Yu, Scott Johnson, Si-Tien Wang, et al.
Pharmacoeconomics|October 7, 2009
Cost-effectiveness analysis of adjuvant therapy for operable breast cancer from a Chinese perspective: doxorubicin plus cyclophosphamide versus docetaxel plus cyclophosphamidePeng Liubao, Wan Xiaomin, Tan Chongqing, et al.
Pharmacoeconomics|June 17, 2010
Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic reviewAlok Kapoor, Warren Chuang, Nila Radhakrishnan, et al.
Pharmacoeconomics|June 13, 2014
Cost-utility analysis of chemotherapy regimens in elderly patients with stage III colon cancerDavid R Lairson, Rohan C Parikh, Janice N Cormier, et al.
Pageof 336